Clinical trial

First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050

NCT00607906

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-11-16

PhasePHASE1

Study timeline

Study start (actual)2007-11-16Date precision: day

Registry last updated2017-09-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

SB-756050 immediate release capsuleDRUG

SB-756050 modified release capsuleDRUG

PlaceboDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

MinneapolisMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00607906 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.